Growth in the pharmaceutical and nutraceutical industries, advancements in technology and formulation and rising investments in research and development drive the growth of the global enteric softgel capsules Industry.
NEWARK, DE / ACCESSWIRE / September 2, 2024 / The global enteric softgel capsules market is poised for significant growth over the next decade, according to recent research by Future Market Insights. The market, valued at USD 288.8 million in 2022, is expected to reach USD 305.3 million in 2023, reflecting a year-over-year growth rate of 5.7%. Looking ahead, the market is projected to expand at a compound annual growth rate (CAGR) of 6.7%, reaching a valuation of USD 582.5 million by 2033.
The pharmaceutical industry is the largest consumer of enteric softgel capsules, leveraging their benefits for improved drug delivery and patient compliance. These capsules are commonly used for medications that treat conditions such as inflammatory bowel disease, irritable bowel syndrome, and other gastrointestinal disorders. The ability of enteric softgel capsules to enhance the bioavailability of certain drugs further boosts their appeal in the pharmaceutical sector.
In the nutraceutical industry, enteric softgel capsules are gaining traction due to the rising consumer awareness of health and wellness. Nutritional supplements that are sensitive to stomach acid, such as omega-3 fatty acids and certain probiotics, are increasingly being formulated in enteric softgel form to ensure optimal absorption and efficacy. This trend is expected to drive substantial growth in the market over the forecast period.
The global enteric softgel capsules market is also benefiting from advancements in encapsulation technology, which have led to the development of more effective and reliable products. As a result, the market is expected to continue its upward trajectory, with significant opportunities for growth in both established and emerging markets.
Key Takeaways Enteric Softgel Capsules Market:
The enteric softgel capsules market is anticipated to grow from USD 305.3 million in 2023 to USD 582.5 million by 2033.
The market is expected to grow at a robust CAGR of 6.7% during the forecast period.
Increasing demand for targeted drug delivery, coupled with advancements in capsule formulation technology, are key factors driving this growth.
"This positive outlook for the enteric softgel capsules market underscores the growing importance of advanced drug delivery systems and the expanding role of softgel capsules in the pharmaceutical industry." Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Competitive Landscape
Leading companies in the enteric softgel capsules market are increasingly focusing on strategic partnerships to innovate and expand their global reach.
For instance, in December 2020, GELITA AG bolstered its industry leadership by acquiring a 65% stake in the Turkish gelatin manufacturer SelJel. Additionally, the team at Future Market Insights has monitored other recent activities and developments in the enteric softgel capsules market, which are detailed in the full report.
Key Players of Enteric Softgel Capsules Market:
GELITA AG
Catalent Inc
Renown Pharmaceuticals Pvt. Ltd.
InovoBiologic Inc
Viva Pharmaceutical,
Aenova Group
Basf Se
Lonza Group Ltd
Procaps Laboratory
Sirio Pharma Co Ltd.
Get Full Report URL: https://www.futuremarketinsights.com/reports/enteric-softgel-capsules-market
Key Market Segments Covered in Enteric Softgel Capsules Industry Research:
By Product:
Gelatin Softgel Capsules
Vegetarian Softgel Capsules
By Raw Material:
Type-A Gelatin (Pork Skin)
Type-B Gelatin (Animal Bones and Skin)
Fish Bone Gelatin
Cellulose Derivatives
Starch Material
By Application:
Antacid and Antiflatulent Preparations
Anti-inflammatory Drugs
Antibiotic and Antibacterial Drugs
Cough and Cold Preparations
Health Supplements
Vitamin and Dietary Supplements
Other Therapeutic Applications
By End User:
Pharmaceutical Companies
Nutraceutical Companies
Cosmeceutical Companies
Food Industry
By Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Have a Look at the Related Report from the Enteric Softgel Capsules Market:
The global softgel capsules market is expected to enjoy a valuation of US$ 1.1 Billion by the end of the year 2022, and further expand at a CAGR of 6.0% to reach a valuation of US$ 1.9 Billion by the year 2032.
The projected scope of the global breathing circuit market size is expected to reach USD 21.6 billion by 2034, developing at a sluggish CAGR of 3.5% through the forecasted era.
The dental ceramic market forecast suggests that the sector is on track to reach USD 385.6 million in 2024. The projected elevation of the global dental ceramic market size is set to help the industry reach USD 664.9 million by 2034.
The global manual resuscitator market is estimated to be worth USD 647.6 million in 2024. Displaying a CAGR of 6.4% through 2034, the industry is slated to be worth USD 1,204.3 million by the end of the forecast period.
The global ophthalmic combination product market is estimated to be valued at USD 12.9 billion in 2024 and USD 25.9 billion by 2034.
The cell free cartilage repair global industry size is estimated to total USD 1,029.3 million in 2024 and USD 2,092.4 million by 2034.
The global psoriatic arthritis (PsA) treatment market is set to acquire a value of USD 11,973.7 million in 2024. By 2034, the value of the psoriatic arthritis (PsA) treatment market is slated to shoot upwards of USD 25,375.6 million.
The global endoscopy visualization system and component market is expected to hit a valuation of USD 4,416.7 million by 2034.
The global insulin delivery pen market is estimated to record a CAGR of 8.1% from 2024 to 2034. This is likely to take the market value from an estimated USD 26,408.7 million in 2024 to a projected USD 57,544.5 million by 2034.
The clinical oncology next-generation sequencing market size stands at USD 635 million in 2024. The clinical oncology NGS market size is set to rise at a 17.3% CAGR through 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website:https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
SOURCE: Future Market Insights Inc.
View the original press release on accesswire.com
